Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -99.54%1.19M | -99.91%187K | -89.81%6.44M | 1.18M | -22.22%242.86M | 256.43M | 219.85%216.38M | -86.80%63.21M | 98.33%312.24M | 67.65M |
| Cost of revenue | -86.35%12.85M | -79.56%94.18M | ||||||||
| Gross profit | 79.31%-6.41M | -272.52%-30.97M | ||||||||
| Operating expense | -54.54%55.5M | -84.03%122.07M | 40.87M | |||||||
| Selling and administrative expenses | ---- | ---- | -66.58%25.24M | ---- | ---- | ---- | ---- | -43.49%75.52M | ---- | ---- |
| -General and administrative expense | ---- | ---- | -66.58%25.24M | ---- | ---- | ---- | ---- | -43.49%75.52M | ---- | ---- |
| Other operating expenses | ---- | ---- | -35.73%48.36M | ---- | ---- | ---- | ---- | -89.38%75.25M | ---- | --40.87M |
| Total other operating income | ---- | ---- | -36.92%18.1M | ---- | ---- | ---- | ---- | -63.25%28.7M | ---- | ---- |
| Operating profit | -462.74%-46.45M | -166.98%-7M | 59.55%-61.91M | 13.26M | 1,337.31%242.86M | 12.8M | -60.96%10.46M | 79.49%-153.04M | 137.81%16.9M | 26.78M |
| Net non-operating interest income (expenses) | 49.55%-112.31M | -24.35M | -23.90%-222.62M | -33.26M | ||||||
| Non-operating interest income | -94.96%27K | --0 | -94.66%327K | --30K | -65.94%784K | --536K | --0 | 1,754.55%6.12M | 115,000.00%2.3M | --474K |
| Non-operating interest expense | 1.16%26.24M | -1.21%25.59M | -50.57%112.53M | --35.17M | 23.99%25.13M | --25.94M | -23.20%25.9M | 30.43%227.68M | -46.90%20.27M | --33.73M |
| Total other finance cost | ---- | ---- | -90.01%106K | ---- | ---- | ---- | ---- | -80.51%1.06M | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 60.19%-12.94M | -32.5M | ||||||||
| Less:Write off | ---- | ---- | -60.19%12.94M | ---- | ---- | ---- | ---- | --32.5M | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -476.55%-72.66M | -110.99%-32.59M | 54.15%-187.16M | -21.88M | -5,884.97%-64.1M | -12.6M | 79.16%-15.45M | 55.92%-408.16M | 98.71%-1.07M | -74.13M |
| Income tax | -100.16%-8K | -99.90%14K | 100.52%134K | 18K | -50.53%5.73M | 5.06M | 363.46%13.38M | -2,862.85%-25.58M | 259.42%11.59M | -5.08M |
| Net income | -897.01%-68.6M | 71.24%-23.04M | 61.50%-162M | 6.59M | 11.27%-80.19M | -6.88M | -89.20%-80.13M | 51.33%-420.83M | -19.55%-90.37M | -42.35M |
| Net income continuous operations | -311.43%-72.65M | -13.09%-32.61M | 51.04%-187.29M | ---21.89M | -451.55%-69.83M | ---17.66M | 58.24%-28.83M | 58.72%-382.57M | 83.25%-12.66M | ---69.05M |
| Net income discontinuous operations | -62.42%4.05M | 118.64%9.56M | 166.11%25.29M | --28.49M | 86.68%-10.35M | --10.78M | -292.16%-51.3M | -161.55%-38.25M | ---77.71M | --26.7M |
| Noncontrolling interests | -0.26%-3.41M | 22.54%-3.42M | 38.39%-16.48M | -4.41M | 48.64%-3.02M | -3.4M | 6.59%-4.41M | 29.74%-26.75M | -144.65%-5.87M | -4.72M |
| Net income attributable to the company | -1,772.37%-65.2M | 74.08%-19.63M | 63.07%-145.52M | 11M | 8.67%-77.17M | -3.48M | -101.22%-75.72M | 52.33%-394.07M | 4.78%-84.5M | -37.63M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1,772.37%-65.2M | 74.08%-19.63M | 63.07%-145.52M | 11M | 8.67%-77.17M | -3.48M | -101.22%-75.72M | 52.33%-394.07M | 4.78%-84.5M | -37.63M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -1,688.89%-0.0161 | 73.80%-0.0049 | 64.46%-0.036 | 0.0027 | 15.11%-0.0191 | -0.0009 | -83.33%-0.0187 | 58.16%-0.1013 | 13.46%-0.0225 | -0.0102 |
| Diluted earnings per share | -1,688.89%-0.0161 | 73.80%-0.0049 | 64.46%-0.036 | 0.0027 | 15.11%-0.0191 | -0.0009 | -83.33%-0.0187 | 58.16%-0.1013 | 13.46%-0.0225 | -0.0102 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.